- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Is GFR decline induced by SGLT2 inhibitor of clinical importance? ; volume:23 ; number:1 ; day:29 ; month:5 ; year:2024 ; pages:1-12 ; date:12.2024
Cardiovascular diabetology ; 23, Heft 1 (29.5.2024), 1-12, 12.2024
- Urheber
-
Günes-Altan, Merve
Bosch, Agnes
Striepe, Kristina
Bramlage, Peter
Schiffer, Mario
Schmieder, Roland E.
Kannenkeril, Dennis
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-024-02223-0
- URN
-
urn:nbn:de:101:1-2408062123020.314157847517
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Günes-Altan, Merve
- Bosch, Agnes
- Striepe, Kristina
- Bramlage, Peter
- Schiffer, Mario
- Schmieder, Roland E.
- Kannenkeril, Dennis
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effects of SGLT2 inhibitors on eGFR in type 2 diabetic patients—the role of antidiabetic and antihypertensive medications
Direct cardiac effects of SGLT2 inhibitors
SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere
Comparison of incident hypertension between SGLT2 inhibitors vs. DPP4 inhibitors
Blood pressure and age-related GFR decline in the general population
Class effects of SGLT2 inhibitors on cardiorenal outcomes
SGLT2-inhibitors; more than just glycosuria and diuresis
The potential anti-arrhythmic effect of SGLT2 inhibitors
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
SGLT2 inhibitors in heart failure with reduced ejection fraction
Effects of SGLT2 inhibitors on eGFR in type 2 diabetic patients—the role of antidiabetic and antihypertensive medications
Direct cardiac effects of SGLT2 inhibitors
SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere
Comparison of incident hypertension between SGLT2 inhibitors vs. DPP4 inhibitors
Blood pressure and age-related GFR decline in the general population
Class effects of SGLT2 inhibitors on cardiorenal outcomes
SGLT2-inhibitors; more than just glycosuria and diuresis
The potential anti-arrhythmic effect of SGLT2 inhibitors
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
SGLT2 inhibitors in heart failure with reduced ejection fraction
Effects of SGLT2 inhibitors on eGFR in type 2 diabetic patients—the role of antidiabetic and antihypertensive medications
Direct cardiac effects of SGLT2 inhibitors
SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere
Comparison of incident hypertension between SGLT2 inhibitors vs. DPP4 inhibitors
Blood pressure and age-related GFR decline in the general population
Class effects of SGLT2 inhibitors on cardiorenal outcomes
SGLT2-inhibitors; more than just glycosuria and diuresis
The potential anti-arrhythmic effect of SGLT2 inhibitors
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
SGLT2 inhibitors and the cardiac rhythm: unraveling the connections